Gilead Joining the Global Access to Oncology Medicines Coalition
By:
3BL Media
June 08, 2022 at 05:55 AM EDT
SOURCE: Gilead Sciences DESCRIPTION:We’re pleased to announce that we're joining the global Access to Oncology Medicines (ATOM) Coalition to help improve care and access to essential cancer medicines in low- and lower middle-income countries. https://gilead.inc/39Gb9nb About Gilead Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California. View original content here KEYWORDS: NYSE: GILD, Gilead Sciences, ATOM
More NewsView More
Why Taiwan Semiconductor's 6.5% Dip Could Be a Smart Buy ↗
December 16, 2025
Via MarketBeat
RTX Surges to Record Highs as Defense Orders Explode ↗
December 16, 2025
Via MarketBeat
Tickers
RTX
Smart Money Is Buying Auto Suppliers, Not Car Brands ↗
December 16, 2025
Higher Beef Prices Are Here: Best Steakhouse Stocks for 2026 ↗
December 16, 2025
Via MarketBeat
AI Runs on Power—And Constellation Energy Controls the Switch ↗
December 16, 2025
Recent QuotesView More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
>